Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[PCSK9 inhibitors on reimbursable prescription: who is eligible?].
Semb AG, Vesterbekkmo EK, Retterstøl K, Atar D, Solberg EE, Schirmer H, Løchen ML, Kask A, Grimsmo J, Ingul CB, Munkhaugen J. Semb AG, et al. Among authors: retterstol k. Tidsskr Nor Laegeforen. 2023 May 29;143(8). doi: 10.4045/tidsskr.23.0191. Print 2023 May 30. Tidsskr Nor Laegeforen. 2023. PMID: 37254976 Free article. Norwegian. No abstract available.
[Lower treatment goals for LDL cholesterol should be introduced].
Retterstøl K, Munkhaugen J, Ingul CB, Grimsmo J, Kask A, Schirmer H, Semb AG, Solberg EE. Retterstøl K, et al. Tidsskr Nor Laegeforen. 2021 Jan 22;141(2). doi: 10.4045/tidsskr.20.0761. Print 2021 Feb 2. Tidsskr Nor Laegeforen. 2021. PMID: 33528123 Free article. Norwegian. No abstract available.
[Retterstøl and colleagues respond].
Retterstøl K, Munkhaugen J, Igul CB, Grimsmo J, Kask A, Schirmer H, Semb AG, Solberg EE. Retterstøl K, et al. Tidsskr Nor Laegeforen. 2021 Mar 8;141(4). doi: 10.4045/tidsskr.21.0122. Print 2021 Mar 9. Tidsskr Nor Laegeforen. 2021. PMID: 33685109 Free article. Norwegian. No abstract available.
[Correction: Lower treatment goals for LDL cholesterol should be introduced].
Retterstøl K, Munkhaugen J, Ingul CB, Grimsmo J, Kask A, Schirmer H, Semb AG, Solberg EE. Retterstøl K, et al. Tidsskr Nor Laegeforen. 2021 Feb 22;141(4). doi: 10.4045/tidsskr.21.0096. Print 2021 Mar 9. Tidsskr Nor Laegeforen. 2021. PMID: 33685112 Free article. Norwegian. No abstract available.
Statins seldom cause adverse reactions.
Munkhaugen J, Kristiansen O, Sverre E, Retterstøl K, Tonstad S. Munkhaugen J, et al. Among authors: retterstol k. Tidsskr Nor Laegeforen. 2022 Jan 20;142(2). doi: 10.4045/tidsskr.21.0885. Print 2022 Feb 1. Tidsskr Nor Laegeforen. 2022. PMID: 35107944 Free article. English, Norwegian.
High levels of lipoprotein(a) - assessment and treatment.
Svilaas T, Klemsdal TO, Bogsrud MP, Græsdal A, Vesterbekkmo EK, Asprusten EA, Langslet G, Retterstøl K. Svilaas T, et al. Among authors: retterstol k. Tidsskr Nor Laegeforen. 2022 Dec 16;142(1). doi: 10.4045/tidsskr.21.0800. Print 2023 Jan 17. Tidsskr Nor Laegeforen. 2022. PMID: 36655975 Free article. Review. English, Norwegian.
[Correction: High levels of lipoprotein(a) – assessment and treatment].
Svilaas T, Klemsdal TO, Bogsrud MP, Græsdal A, Vesterbekkmo EK, Asprusten EA, Langslet G, Retterstøl K. Svilaas T, et al. Among authors: retterstol k. Tidsskr Nor Laegeforen. 2023 Jan 17;143(2). doi: 10.4045/tidsskr.23.0023. Print 2023 Jan 31. Tidsskr Nor Laegeforen. 2023. PMID: 36718898 Free article. Norwegian. No abstract available.
The Long-term Effect of Different Exercise Intensities on High-Density Lipoprotein Cholesterol in Older Men and Women Using the Per Protocol Approach: The Generation 100 Study.
Berglund I, Vesterbekkmo EK, Retterstøl K, Anderssen SA, Fiatarone Singh MA, Helge JW, Lydersen S, Wisløff U, Stensvold D. Berglund I, et al. Among authors: retterstol k. Mayo Clin Proc Innov Qual Outcomes. 2021 Sep 16;5(5):859-871. doi: 10.1016/j.mayocpiqo.2021.07.002. eCollection 2021 Oct. Mayo Clin Proc Innov Qual Outcomes. 2021. PMID: 34585083 Free PMC article.
185 results